Scandinavian Tobacco Group AS (OTCPK:SNDVF)
$ 10.25 -0.50 (-4.65%) Market Cap: 791.03 Mil Enterprise Value: 1.58 Bil PE Ratio: 7.87 PB Ratio: 0.60 GF Score: 68/100

Q2 2025 Scandinavian Tobacco Group A/S Earnings Call Transcript

Aug 28, 2025 / 08:00AM GMT
Release Date Price: $13.89

Key Points

Positve
  • Scandinavian Tobacco Group AS (SNDVF) reported a recovery in organic net sales for handmade cigars in the second quarter, showing a 1% growth compared to a weak first quarter.
  • The integration of acquired businesses is progressing well, with expected synergies of DKK150 million by 2027.
  • Retail stores in the US and the nicotine pouch brand SS delivered double-digit sales growth, contributing positively to net sales.
  • The company is on track to meet its free cash flow expectations of DKK800 million to DKK1 billion for the full year.
  • The ERP system implementation is progressing as planned, which is expected to improve operational efficiency.
Negative
  • Organic net sales were negatively impacted by the discontinued distribution of sin in the US, resulting in a 3% decline in the second quarter.
  • Margins decreased to 21.1% due to changes in product and market mix and continued investment in market positions.
  • The market for handmade cigars in the US continues to contract, with no major changes expected in the coming quarters.
  • The company faces ongoing challenges in the international market for handmade cigars, particularly in Asia, due to shipment issues.
  • A dispute with the Belgian excise authorities has arisen, although no provisions have been made yet, indicating potential future financial implications.
Unidentified Company Representative

Welcome to Canadian Tobacco Group webcast for the 2nd quarter and first half of 2025 results. My name is Seth Tomam, and I am director of investor relations and external communication. And I am joined by our CEO Milson and our CFO Maan Roselbo. Now please turn to slide number 3 for today's webcast agenda.

Mils will start the presentation by giving you a brief overview of the highlights of the quarter followed by an update on our strategy. The focus will then be switched the nurse giving an update on developments in our core product categories followed by Mayenne, who will give you an update on the financial performance in our three reporting divisions.

Mayan will then turn the focus to key financial developments for the group, including an update on cash flow and leverage. This will conclude by giving an update to our expectations for the full year 2025. After the pre-prepared presentation, we will conduct a Q&A session where we will be more than pleased to take any questions you might have. Before we start, I ask you to pay special attention to our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot